The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Clinical Challenges With Triple-Class or Penta-Refractory MM
Clinical Challenges With Triple-Class or Penta-Refractory MM
Integrating Bispecific Antibodies Into Clinical Practice
Integrating Bispecific Antibodies Into Clinical Practice
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Efficacy Data for Bispecific Antibodies in RRMM
Efficacy Data for Bispecific Antibodies in RRMM
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Managing Immunotherapy Toxicities in Lung Cancer Patients
Managing Immunotherapy Toxicities in Lung Cancer Patients
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease